[Dementia due to cerebral vasculitis].
Kitagawa
Yasuhisa
Y
Department of Neurology, Tokai University Oiso Hospital.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001424:Bacterial Infections; D003520:Cyclophosphamide / Q000627:therapeutic use; D003704:Dementia / Q000209:etiology*; D004359:Drug Therapy, Combination; D013700:Giant Cell Arteritis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009181:Mycoses; D010488:Polyarteritis Nodosa / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D011239:Prednisolone / Q000627:therapeutic use; D012859:Sjogren's Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D020293:Vasculitis, Central Nervous System / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D014777:Virus Diseases
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011239:Prednisolone